• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单一 HA2 突变增强了缺失 NS1 的减毒活 H5N1 鼻内流感疫苗候选株的感染力和免疫原性。

Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.

机构信息

Avir Green Hills Biotechnology AG, Vienna, Austria.

出版信息

PLoS One. 2011 Apr 7;6(4):e18577. doi: 10.1371/journal.pone.0018577.

DOI:10.1371/journal.pone.0018577
PMID:21490925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3072404/
Abstract

BACKGROUND

H5N1 influenza vaccines, including live intranasal, appear to be relatively less immunogenic compared to seasonal analogs. The main influenza virus surface glycoprotein hemagglutinin (HA) of highly pathogenic avian influenza viruses (HPAIV) was shown to be more susceptible to acidic pH treatment than that of human or low pathogenic avian influenza viruses. The acidification machinery of the human nasal passageway in response to different irritation factors starts to release protons acidifying the mucosal surface (down to pH of 5.2). We hypothesized that the sensitivity of H5 HA to the acidic environment might be the reason for the low infectivity and immunogenicity of intranasal H5N1 vaccines for mammals.

METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate that original human influenza viruses infect primary human nasal epithelial cells at acidic pH (down to 5.4), whereas H5N1 HPAIVs lose infectivity at pH ≤ 5.6. The HA of A/Vietnam/1203/04 was modified by introducing the single substitution HA2 58K→I, decreasing the pH of the HA conformational change. The H5N1 reassortants containing the indicated mutation displayed an increased resistance to acidic pH and high temperature treatment compared to those lacking modification. The mutation ensured a higher viral uptake as shown by immunohistochemistry in the respiratory tract of mice and 25 times lower mouse infectious dose₅₀. Moreover, the reassortants keeping 58K→I mutation designed as a live attenuated vaccine candidate lacking an NS1 gene induced superior systemic and local antibody response after the intranasal immunization of mice.

CONCLUSION/SIGNIFICANCE: Our finding suggests that an efficient intranasal vaccination with a live attenuated H5N1 virus may require a certain level of pH and temperature stability of HA in order to achieve an optimal virus uptake by the nasal epithelial cells and induce a sufficient immune response. The pH of the activation of the H5 HA protein may play a substantial role in the infectivity of HPAIVs for mammals.

摘要

背景

与季节性疫苗相比,包括活鼻内接种在内的 H5N1 流感疫苗的免疫原性似乎相对较低。高致病性禽流感病毒(HPAIV)的主要流感病毒表面糖蛋白血凝素(HA)比人类或低致病性禽流感病毒更容易受到酸性 pH 值处理的影响。人类鼻通道的酸化机制对不同的刺激因素开始释放质子酸化粘膜表面(降至 pH5.2)。我们假设 H5HA 对酸性环境的敏感性可能是鼻内接种 H5N1 疫苗对哺乳动物感染力和免疫原性低的原因。

方法/主要发现:我们证明原始人类流感病毒在酸性 pH 值(低至 5.4)下感染原代人鼻上皮细胞,而 H5N1 HPAIV 在 pH≤5.6 时失去感染力。通过引入 HA258K→I 单点替换,修饰 A/Vietnam/1203/04 的 HA,降低了 HA 构象变化的 pH 值。与未修饰的 H5N1 重配体相比,含有该突变的 H5N1 重配体对酸性 pH 值和高温处理具有更高的抗性。该突变确保了更高的病毒摄取率,如呼吸道免疫组化显示在小鼠中以及 25 倍低的小鼠感染剂量₅₀。此外,作为缺乏 NS1 基因的活减毒候选疫苗设计的保留 58K→I 突变的重配体在小鼠鼻内免疫后诱导了更好的系统和局部抗体反应。

结论/意义:我们的发现表明,使用活减毒 H5N1 病毒进行有效的鼻内接种可能需要一定水平的 HA 对 pH 值和温度的稳定性,以实现鼻上皮细胞对病毒的最佳摄取并诱导足够的免疫反应。H5HA 蛋白激活的 pH 值可能在 HPAIV 对哺乳动物的感染力中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/119d549abfa7/pone.0018577.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/c8f603584502/pone.0018577.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/86d5b435fad8/pone.0018577.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/9d937ef73b23/pone.0018577.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/c8cc6e7f7925/pone.0018577.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/6747d1468891/pone.0018577.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/e11f430a52b5/pone.0018577.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/ae62035b48c6/pone.0018577.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/4738b4d5cebc/pone.0018577.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/119d549abfa7/pone.0018577.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/c8f603584502/pone.0018577.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/86d5b435fad8/pone.0018577.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/9d937ef73b23/pone.0018577.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/c8cc6e7f7925/pone.0018577.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/6747d1468891/pone.0018577.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/e11f430a52b5/pone.0018577.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/ae62035b48c6/pone.0018577.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/4738b4d5cebc/pone.0018577.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce8/3072404/119d549abfa7/pone.0018577.g009.jpg

相似文献

1
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.单一 HA2 突变增强了缺失 NS1 的减毒活 H5N1 鼻内流感疫苗候选株的感染力和免疫原性。
PLoS One. 2011 Apr 7;6(4):e18577. doi: 10.1371/journal.pone.0018577.
2
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.新型活流感疫苗M2SR可保护小鼠和雪貂免受高致病性禽流感的侵害。
Vaccine. 2017 Jul 24;35(33):4177-4183. doi: 10.1016/j.vaccine.2017.06.039. Epub 2017 Jun 28.
3
A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.一种缺乏糖蛋白基因并表达流感病毒血凝素和神经氨酸酶的有活力的重组弹状病毒是一种有效的流感疫苗。
J Virol. 2015 Mar;89(5):2820-30. doi: 10.1128/JVI.03246-14. Epub 2014 Dec 24.
4
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.在小鼠模型中对反向遗传学衍生的冷适应主供体病毒A/列宁格勒/134/17/57(H2N2)以及带有H5N1表面基因的重配体进行特性分析。
Clin Vaccine Immunol. 2014 May;21(5):722-31. doi: 10.1128/CVI.00819-13. Epub 2014 Mar 19.
5
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.表达 2.3.4.4b 分支 H5 血凝素蛋白的重组副流感病毒 5 可提供针对 H5Ny 流感病毒的广泛保护。
J Virol. 2024 Mar 19;98(3):e0112923. doi: 10.1128/jvi.01129-23. Epub 2024 Feb 2.
6
Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.NS1缺失的H5N1禽流感减毒活疫苗的跨谱系保护性免疫反应
Vaccine. 2016 Jan 12;34(3):350-7. doi: 10.1016/j.vaccine.2015.11.045. Epub 2015 Nov 27.
7
Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.重组副流感病毒 5 疫苗编码流感病毒血凝素,通过滴鼻或肌肉注射免疫 BALB/c 小鼠,可预防 H5N1 高致病性禽流感病毒感染。
J Virol. 2013 Jan;87(1):363-71. doi: 10.1128/JVI.02330-12. Epub 2012 Oct 17.
8
Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.针对快速进化的H5亚型病毒开发具有分支特异性和广泛反应性的减毒活流感病毒疫苗。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00547-17. Print 2017 Aug 1.
9
Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.缺失 NS1 的复制缺陷型 H5N1 流感病毒疫苗的安全性和免疫原性。
Vaccine. 2019 Jun 19;37(28):3722-3729. doi: 10.1016/j.vaccine.2019.05.013. Epub 2019 May 30.
10
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.含有NS1截短体的减毒活流感病毒作为抗H5N1高致病性禽流感的候选疫苗。
J Virol. 2009 Feb;83(4):1742-53. doi: 10.1128/JVI.01920-08. Epub 2008 Dec 10.

引用本文的文献

1
Influenza B viruses are more susceptible to high temperatures than influenza A viruses.乙型流感病毒比甲型流感病毒对高温更敏感。
Npj Viruses. 2024 Dec 16;2(1):65. doi: 10.1038/s44298-024-00077-7.
2
Relationship between protein conformational stability and its immunogenicity when administering antigens to mice using adjuvants-Analysis employed the CH2 domain in human antibodies.在使用佐剂将抗原施用于小鼠时,蛋白质构象稳定性与其免疫原性之间的关系 - 分析采用了人抗体的 CH2 结构域。
PLoS One. 2024 Jul 22;19(7):e0307320. doi: 10.1371/journal.pone.0307320. eCollection 2024.
3
Current Opinion in LAIV: A Matter of Parent Virus Choice.

本文引用的文献

1
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.影响血凝素分子稳定性的突变会损害缺乏 NS1 的减毒活 H3N2 鼻内流感疫苗候选物的免疫原性。
Vaccine. 2011 Apr 27;29(19):3517-24. doi: 10.1016/j.vaccine.2011.02.100. Epub 2011 Mar 12.
2
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses.季节性和大流行性人流感病毒比禽流感病毒更容易附着在人类上呼吸道上皮细胞上。
Am J Pathol. 2010 Apr;176(4):1614-8. doi: 10.2353/ajpath.2010.090949. Epub 2010 Feb 18.
3
LAIV 现状:选择亲本病毒是关键。
Int J Mol Sci. 2022 Jun 19;23(12):6815. doi: 10.3390/ijms23126815.
4
Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.血凝素稳定性及其对禽类、小鼠、猪、海豹、雪貂和人类中流感 A 病毒感染力、致病性和传染性的影响。
Viruses. 2021 Apr 24;13(5):746. doi: 10.3390/v13050746.
5
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.嵌合A/B型减毒活流感疫苗在小鼠模型中的安全性、免疫原性及保护效力
Microorganisms. 2021 Jan 27;9(2):259. doi: 10.3390/microorganisms9020259.
6
Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.血凝素稳定性通过调节树突状细胞中的 I 型干扰素反应来调节 H1N1 流感病毒在小鼠中的复制和致病性。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01423-19.
7
HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.H5N1 和 H7N9 流感病毒对人内皮细胞的 HA 依赖性嗜性由 HA 的稳定性降低决定,这使病毒能够应对内体酸化效率低下和组成型表达的 IFITM3。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01223-19.
8
Inventory of molecular markers affecting biological characteristics of avian influenza A viruses.影响甲型禽流感病毒生物学特性的分子标志物清单。
Virus Genes. 2019 Dec;55(6):739-768. doi: 10.1007/s11262-019-01700-z. Epub 2019 Aug 19.
9
Biological properties of influenza A virus mutants with amino acid substitutions in the HA2 glycoprotein of the HA1/HA2 interaction region.具有 HA1/HA2 相互作用区域中 HA2 糖蛋白氨基酸取代的流感 A 病毒突变体的生物学特性。
J Gen Virol. 2019 Sep;100(9):1282-1292. doi: 10.1099/jgv.0.001305.
10
Why Do Exceptionally Dangerous Gain-of-Function Experiments in Influenza?为何要在流感领域开展极其危险的功能获得性实验?
Methods Mol Biol. 2018;1836:589-608. doi: 10.1007/978-1-4939-8678-1_29.
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
一种新型流感疫苗:通过缺失干扰素拮抗剂 NS1 而产生的复制缺陷型流感病毒的安全性和免疫原性。
J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428.
4
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks.血凝素蛋白的激活 pH 值调节 H5N1 流感病毒在鸭子中的致病性和传染性。
J Virol. 2010 Feb;84(3):1527-35. doi: 10.1128/JVI.02069-09. Epub 2009 Nov 18.
5
Aerosol transmission of influenza A virus: a review of new studies.甲型流感病毒气溶胶传播:新研究综述。
J R Soc Interface. 2009 Dec 6;6 Suppl 6(Suppl 6):S783-90. doi: 10.1098/rsif.2009.0302.focus. Epub 2009 Sep 22.
6
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.一种复制缺陷型鼻内DeltaNS1 H5N1流感疫苗的临床前评估。
PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984.
7
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.两种减毒活冷适应H5N1流感病毒疫苗在健康成年人中的评估。
Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21.
8
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).减毒活流感重组H5疫苗的安全性和免疫原性(I-II期临床试验)
Influenza Other Respir Viruses. 2008 Nov;2(6):203-9. doi: 10.1111/j.1750-2659.2008.00064.x.
9
Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways.禽流感病毒糖蛋白在近端气道温度下限制病毒在人气道上皮中的复制和传播。
PLoS Pathog. 2009 May;5(5):e1000424. doi: 10.1371/journal.ppat.1000424. Epub 2009 May 15.
10
Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein.融合肽口袋中的氨基酸残基调节H5N1流感病毒血凝素蛋白的激活pH值。
J Virol. 2009 Apr;83(8):3568-80. doi: 10.1128/JVI.02238-08. Epub 2009 Feb 4.